AIDS 2010: Track B (Clinical Science) Highlights
-
Upload
gage-pierce -
Category
Documents
-
view
28 -
download
1
description
Transcript of AIDS 2010: Track B (Clinical Science) Highlights
![Page 1: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/1.jpg)
AIDS 2010: Track B (Clinical Science) Highlights
Dr. Andrew Kambugu, Uganda (Lead) Jain Vivek, USADr. Gabriel Chamie, USADr. Sabrina Kitaka-Bakera, UgandaDr. Jose Arribas, SpainDr. N. Kumarasamy, IndiaDr. Annie Luetkemeyer, USADr. Ted Ruel UCSF, USA
![Page 2: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/2.jpg)
Track B Stats
AIDS 2010: Track BOA
PD
PE
REJECTED
WITHDRAWN
Result Track B
OA 56
PD 46
PE 544
REJECTED 349
WITHDRAWN 3
TOTAL 998
![Page 3: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/3.jpg)
Structure of Report
• ART: New Drugs and Novel Treatment Strategies• New ART products• Simplification / Switching
• When to Start ART• Co-infections/Co-morbidities
• HIV/TB co-infection• HIV/Hepatitis co-infection• HIV and Malignancies
• Complications of HIV and ART• Monitoring of ART• Paediatrics
![Page 4: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/4.jpg)
Promising Next-generation INI-ING112276
![Page 5: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/5.jpg)
A Nucleoside-Sparing Strategy- The PROGRESS Study
![Page 6: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/6.jpg)
MOAB0103-SPIRAL SLIDE
Treatment Simplification- The SPIRAL Study
![Page 7: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/7.jpg)
Treatment Simplification- The SPARTAN Study
![Page 8: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/8.jpg)
CASCADE-1
When to Start ART- The CASCADE Collaboration
AIDS 2010: THLBB201
![Page 9: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/9.jpg)
CASCADE-2
When to Start ART- The CASCADE Collaboration
AIDS 2010: THLBB201
![Page 10: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/10.jpg)
When to Start ART- The CHER Trial Analysis (Paeds)
![Page 11: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/11.jpg)
When to Start ART- The CAMELIA Trial (TB)
![Page 12: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/12.jpg)
TB/HIV Co-Infection- The Role of IPT in RLS (MOAB0305)
AIDS 2010: MOAB0305
![Page 13: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/13.jpg)
TUAB0104 Slide
HIV/Hepatitis Co-Infection- Risk of Fractures (TUAB0104)
AIDS 2010: TUAB0104
![Page 14: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/14.jpg)
HIV and Malignancies- Higher Burden in HIV (WEAB0101)
AIDS 2010: WEAB0101
![Page 15: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/15.jpg)
?WEAB0304- HIV Comps
HIV and Bone Disease- Association with ART Regimens (WEAB0304)
AIDS 2010: WEAB0304
![Page 16: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/16.jpg)
THAB0102: Monitoring Slide
ART Monitoring: VL vs Non VL sites (THAB0102)
AIDS 2010: THAB0102
![Page 17: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/17.jpg)
THLBB104-PENPACT Slide
Paediatric ART: The PENPACT Study (THLBB104)
AIDS 2010: THLBB104
![Page 18: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/18.jpg)
What Next After CAPRISA 004?
![Page 19: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/19.jpg)
Key Messages
• Newer Drugs may offer simpler, less toxic regimens while maintaining HIV suppression• Nucleoside-sparing regimens (SPARTAN, PROGRESS)
• Start ART earlier• Certain: CD4 less than 350, TB, Peads• Less certain: CD4 less than 500 but >350
• TB and ART: Initiate ART at the earliest opportunity • The CAMELIA
![Page 20: AIDS 2010: Track B (Clinical Science) Highlights](https://reader036.fdocuments.in/reader036/viewer/2022062321/568132e3550346895d999f36/html5/thumbnails/20.jpg)
Track B Rapporteur Team
• Dr. Andrew D Kambugu IDI Uganda• Dr. Jain Vivek, UCSF, USA• Dr. Gabriel Chamie, UCSF, USA• Dr. Sabrina Kitaka-Bakera, Makerere, Uganda• Dr. Jose Arribas, Madrid, Spain• Dr. N. Kumarasamy, Chenai, India• Dr. Annie Luetkemeyer, UCSF, USA• Dr. Ted Ruel UCSF, USA